Literature DB >> 7107381

In vitro pre-incubation with misonidazole under hypoxic conditions--effect on drug response of EMT6 spheroids.

P R Twentyman.   

Abstract

We have studied the effect of pretreating small (approximately 250 mu diameter) EMT6 spheroids with 5mM misonidazole under hypoxic conditions upon their subsequent response to a number of cytotoxic drugs. Growth delay assay was used to quantify spheroid response. The pretreatment time was either 3 or 5 hours. Such pretreatment produced an increase in spheroid response to nitrogen mustard, melphalan, chlorambucil, BCNU and CCNU but a reduction in the response to adriamycin. The relative effects of 3 hr and 5 hr pretreatment varied among the drugs. In the case of melphalan and CCNU we have shown that the increased growth delay is not caused by any inhibition of recovery from potentially lethal drug damage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107381     DOI: 10.1016/0360-3016(82)90694-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  A high-throughput photodynamic therapy screening platform with on-chip control of multiple microenvironmental factors.

Authors:  Xia Lou; Gwangseong Kim; Hyung Ki Yoon; Yong-Eun Koo Lee; Raoul Kopelman; Euisik Yoon
Journal:  Lab Chip       Date:  2014-03-07       Impact factor: 6.799

2.  Misonidazole and CCNU chemotherapy for recurrent primary brain tumor.

Authors:  D S Fulton; R C Urtasun; S McKinnon; H Tanasichuk
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 3.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Effect of misonidazole pretreatment on nitrogen mustard-induced DNA cross-linking in mouse tissues in vivo.

Authors:  D Murray; R E Meyn
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

5.  Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.

Authors:  P Workman; P R Twentyman
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.